Experts Matter. Find Yours.

Covering Hurricane Melissa? Our Expert is Here to Help with Your Coverage

Hurricane Melissa has exploded into a record-breaking Category 5 storm, tearing through the Caribbean with catastrophic force. It made landfall in Jamaica with sustained winds near 185 mph, unleashing torrential rain, landslides, and widespread destruction across the island — the strongest storm ever recorded there. The hurricane has already caused fatalities in Jamaica, Haiti, and the Dominican Republic, and now barrels toward eastern Cuba and the Bahamas, where mass evacuations are underway. Meteorologists warn of up to 30 inches of rainfall in some areas, storm surges reaching 11 feet along southern coasts, and a severe risk of flash flooding and mudslides due to the storm’s slow, grinding pace.  Dr. J. Marshall Shepherd is a leading international weather-climate expert and is the Georgia Athletic Association Distinguished Professor of Geography and Atmospheric Sciences at the University of Georgia. Dr. Shepherd was the 2013 President of American Meteorological Society (AMS), the nation’s largest and oldest professional/science society in the atmospheric and related sciences. View his profile here While Melissa is expected to weaken slightly as it moves north, its enormous size means destructive winds, life-threatening flooding, and dangerous coastal waves will persist through the week — with Bermuda now bracing for potential impact and the U.S. East Coast monitoring for high surf and rip currents as the storm churns offshore. Covering?  We can help. Dr. J. Marshall Shepherd is a leading international weather-climate expert and is the Georgia Athletic Association Distinguished Professor of Geography and Atmospheric Sciences at the University of Georgia. His expertise has been sought recently by ABC News, Forbes Magazine and The New York Times. He's available to speak with the media about this ongoing story and storm - simply click on his icon now to arrange an interview today.

Experts in the Media: CBD may help treat and reduce inflammation in Alzheimer's disease

In a recent Medical News Today article, Corrie Pelc reported on a study led by Babak Baban, PhD, in which inhaled CBD (cannabidiol) was tested in a mouse model of Alzheimer’s disease to examine its effects on neuroinflammation. Baban, associate dean for Research with AU's Dental College of Georgia and a professor with appointments in neurology and surgery in the Medical College of Georgia at Augusta University, explained that previous work from his group showed inhaled CBD to be more effective than oral or injected forms for certain neurological conditions, motivating them to explore its potential in Alzheimer’s research. He emphasized that Alzheimer’s is driven by multiple interacting biological processes – not just amyloid plaques – and sees inflammation as a promising new therapeutic target. In the study, inhaled CBD lowered activity in two major immune “alarm” pathways – IDO (indoleamine 2,3-dioxygenase) and cGAS-STING – both implicated in chronic inflammation. By dampening these pathways, CBD reduced levels of inflammatory cytokines and helped restore a more balanced immune environment in the brain. Baban framed this as a shift from symptom treatment to addressing underlying immune dysfunction, and noted that the findings could reorient how Alzheimer’s is approached. At the same time, he stressed that human trials are still needed: his team is preparing translational studies and holds an active Investigational New Drug (IND) application with the FDA for inhaled CBD in neuroinflammatory conditions, with Alzheimer’s disease as a natural next step. Read the full article here: Babak Baban, PhD, is a professor, immunologist and associate dean for research at the Dental College of Georgia at Augusta University where he has served for 13 of his 20 years as a translational and clinical immunologist. View his profile here Looking to know more about this important research or to connect with Babak Baban, PhD? He's available to speak with media – simply click on his icon to arrange an interview today.

Expert Insight: UGA Franklin College of Arts and Sciences' Marshall Shepherd was recently featured in Forbes Magazine

In a September article featured in Forbes, Marshall Shepherd reports on a new tool launched by Project Drawdown that aims to deliver personalized climate-action strategies to different users—including policymakers, businesses, and individuals. In the piece, he explains that the tool helps match context-specific emissions reduction or resilience options to the particular needs, geography, and capacities of the user, rather than prescribing one-size-fits-all solutions. Shepherd also emphasizes that tools like this can help bridge the gap between climate science and real-world decision-making. He argues that equipping stakeholders with tailored pathways could accelerate uptake of effective interventions by making them more relevant, feasible, and compelling. Ultimately, Shepherd presents the new Drawdown resource as a promising model for democratizing access to climate solutions, enabling individuals and organizations to engage in strategies best suited to their specific circumstances. Dr. J. Marshall Shepherd is a leading international weather-climate expert and is the Georgia Athletic Association Distinguished Professor of Geography and Atmospheric Sciences at the University of Georgia. Dr. Shepherd was the 2013 President of American Meteorological Society (AMS), the nation’s largest and oldest professional/science society in the atmospheric and related sciences. View his profile here Dr. J. Marshall Shepherd is a leading international weather-climate expert and is the Georgia Athletic Association Distinguished Professor of Geography and Atmospheric Sciences at the University of Georgia. He's available to speak with the media about this topic - simply click on his icon now to arrange an interview today.

3 Things A Climate Scientist Learned From Jane Goodall

In a recent Forbes article, Marshall Shepherd reflects on three key lessons he has drawn from the life and work of Dr. Jane Goodall. Shepherd frames Goodall’s legacy—spanning primatology, conservation, and public engagement—as deeply instructive for climate scientists and environmental advocates. He argues that her methods and mindset have more to teach than simply how to observe nature; they speak to how we engage with the world. First, Shepherd highlights immersion: Goodall’s decades of patient observation in the Tanzanian forests demonstrates the power of being physically—and emotionally—present to truly learn from ecosystems. For Shepherd, climate science must go beyond remote data collection: getting into the field and understanding local realities matters. Second, he emphasizes patience. Goodall’s willingness to wait, sometimes for years, for breakthroughs in understanding primate behavior offers a lesson for climate researchers, whose progress may unfold over decades. Third, he admires her tenacity—a commitment sustained over a lifetime, even under adversity. Shepherd suggests that tackling climate change requires that same kind of enduring resolve, especially when public attention or funding waxes and wanes. Through these reflections, Shepherd presents Goodall not just as an icon of conservation but as a model for scientific humility and perseverance. He invites readers to see the parallels between animal behavior research and climate work—and to adopt practices of listening, patience, and resolve in confronting our planet’s changing trajectory. Dr. J. Marshall Shepherd is a leading international weather-climate expert and is the Georgia Athletic Association Distinguished Professor of Geography and Atmospheric Sciences at the University of Georgia. Dr. Shepherd was the 2013 President of American Meteorological Society (AMS), the nation’s largest and oldest professional/science society in the atmospheric and related sciences. View his profile here Dr. J. Marshall Shepherd is a leading international weather-climate expert and is the Georgia Athletic Association Distinguished Professor of Geography and Atmospheric Sciences at the University of Georgia. He's available to speak with the media about this topic - simply click on his icon now to arrange an interview today.

Experts in the Media: Hurricane Season Isn’t Shutdown. A Busy Week Looms For Meteorologists

When you think hurricane season is winding down, think again. Just as many people begin to relax after a stretch of calm weather, the atmosphere often has other plans. Meteorologists are warning that even as we head deeper into October, the tropics are far from done stirring. The “off-season,” as Dr. Marshall Shepherd puts it, can be one of the most deceptive times of year—when attention fades but nature remains restless. Dr. J. Marshall Shepherd is a leading international weather-climate expert and is the Georgia Athletic Association Distinguished Professor of Geography and Atmospheric Sciences at the University of Georgia. Dr. Shepherd was the 2013 President of American Meteorological Society (AMS), the nation’s largest and oldest professional/science society in the atmospheric and related sciences. View his profile here In his recent Forbes article, Shepherd, a leading atmospheric scientist and former president of the American Meteorological Society, reminds readers that the Atlantic hurricane season doesn’t have an on-off switch. While it may appear to be slowing, meteorologists are bracing for a busy week ahead as multiple weather systems continue to develop. He explains that this year’s pattern demonstrates how tropical activity often ebbs and flows, and a lull in storms doesn’t mean the threat has passed. Shepherd highlights how experts are closely watching sea-surface temperatures, wind shear, and atmospheric moisture—factors that can quickly transform calm seas into cyclone breeding grounds. Despite the calendar inching toward November, he warns that conditions remain ripe for sudden storm formation. Ultimately, Shepherd’s message is one of preparedness and respect for nature’s unpredictability. Even when the radar looks clear, the tropics can still surprise us. His call to stay alert is a timely reminder that meteorology is not about predicting the past—it’s about anticipating the next twist in the weather’s unfolding story. Dr. J. Marshall Shepherd is a leading international weather-climate expert and is the Georgia Athletic Association Distinguished Professor of Geography and Atmospheric Sciences at the University of Georgia. He's available to speak with the media about this topic - simply click on his icon now to arrange an interview today.

Nursing researcher receives over $500K in prestigious grants

For the first time in nearly 15 years, a faculty member from Augusta University’s College of Nursing has been awarded a grant from the National Institutes of Health. Blake McGee, PhD, has secured an R03 award of $176,331 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study Medicaid’s expanded role in late postpartum maternal health. But he hasn’t stopped there as McGee is also part of the fifth cohort of Betty Irene Moore Fellows, a prestigious program for nurse leaders and innovators that has awarded CON half a million dollars to support his research project and leadership development. McGee, the prelicensure department chair and an associate professor, is collaborating with colleagues from other Georgia universities on both studies, which are occurring simultaneously. “I began my career as an ER nurse and have always wanted to ask bigger questions about the challenges facing patients and how we might best address them as a society,” said McGee, who was recently selected for publication in Blood Advances, the American Society of Hematology’s journal. “As nursing scientists, we are uniquely poised to ask questions about healthcare policy, specifically from the vantage point of the impact that policy choices have on patients and their health outcomes.” This century, the United States has seen rising maternal mortality rates with alarming racial disparities. Over half of these deaths occur in the postpartum period, with 23% occurring more than six weeks after delivery. Medicaid expansion covers pregnant women in households below 138% of the Federal poverty level through postpartum day 60, which has been associated with decreased mortality and reduced racial disparity in maternal death. At the time of grant submission, pregnancy Medicaid eligibility traditionally lapsed 60 days after delivery, leaving postpartum people vulnerable to disruptions in care. McGee’s work aims to identify changes in maternal health care use and health outcomes 60 days to 1 year after delivery that were associated with state Medicaid expansions (2007–19). The team will examine whether the effects of expansion vary by maternal race or ethnicity and will explore whether patient-reported health care access and quality mediate the relationships between expansion and outcomes. “My hope is that after the study we’ll have a better understanding of how health and health care use change for women in this crucial late postpartum period and how they may differ for people of different backgrounds,” said McGee. “Due to the sample design, findings will reliably inform optimal policy for postpartum coverage duration.” He expects this study to provide preliminary data for a future R01-funded study that directly examines the impact of extending the duration of postpartum Medicaid under the American Rescue Plan. As part of the Betty Irene Moore Fellowship, McGee is one of 15 fellows across the nation in a curriculum co-delivered by the UC Davis School of Nursing and Graduate School of Management. A project coordinator from AU’s School of Public Health will also assist with the fellowship project. McGee hopes to involve graduate research assistants or recent alumni as research associates on the team. Specifically, McGee will be studying the Georgia Pathways to Coverage Program, making him one of the only academic researchers in the nation funded to do so. “As a researcher, it is always a privilege to engage in topics that directly impact the current state of health care, and I’m honored to tackle projects that are so relevant to today’s health policy headlines,” he said. Georgia stands out among other states that are exploring an extension of Medicaid to low-income, working-age adults who demonstrate a monthly commitment of 80 hours to an employment-related activity. By studying the effects of this program, McGee predicts the findings will be highly relevant to anticipating the impact of recent Medicaid changes at the federal level and may indicate differences between Pathways participants and those who might qualify but remain uninsured. This focus could provide data that helps the state target enrollment efforts. The state’s own logic model predicts that the program will reduce hospitalizations, and McGee is eager to determine the program’s success. “Our findings should be helpful to the state to better understand those enrolling, what their experience with increased access to care has been and how their health has improved after receiving coverage,” McGee said.

#Expert Insights: Leaders share insights of Augusta University, Wellstar partnership at Health Connect South

In the two years since Augusta University and Wellstar Health System formally signed an agreement on August 30, 2023, the historic partnership has continued to evolve into a truly collaborative alliance. At its heart, the mission hasn’t changed: improving the health and wellbeing of all Georgians while educating and preparing the next generation of health care providers through access to world-class training. That was the message shared by Augusta University President Russell T. Keen, Medical College of Georgia at Augusta University Dean David C. Hess, MD, and former Wellstar President and CEO Candice L. Saunders at the recent Health Connect South conference held at the Georgia Aquarium in Atlanta. During their panel “Advancing Healthcare Through Public-Private Partnerships,” the three leaders – each instrumental in helping to create, implement and mold the historic partnership – shared with close to 1,100 attendees their insight into what makes the partnership beneficial for all and how it can be a model for advancing health care and health care education in Georgia and beyond. The full panel discussion is available for viewing here: It was an important event, and a full article is attached below as well. And if you're interested in learning more about the partnership between Augusta University and Wellstar, or connect with Augusta's President Russell T. Keen - simply click on his icon now to arrange an interview today.

First scientific paper on 3I/ATLAS interstellar object

When the news started to spread on July 1, 2025, about a new object that was spotted from outside our solar system, only the third of its kind ever known, astronomers at Michigan State University — along with a team of international researchers — turned their telescopes to capture data on the new celestial sighting. The team rushed to write a scientific paper on what they know so far about the object, now called 3I/ATLAS, after NASA’s Asteroid Terrestrial-impact Last Alert System, or ATLAS. ATLAS consists of four telescopes — two in Hawaii, one in Chile and one in South Africa — which automatically scans the whole sky several times every night looking for moving objects. MSU’s Darryl Seligman, a member of the scientific team and an assistant professor in the College of Natural Science, took the lead on writing the paper. “I heard something about the object before I went to bed, but we didn’t have a lot of information yet,” Seligman said. “By the time I woke up around 1 a.m., my colleagues, Marco Micheli from the European Space Agency and Davide Farnocchia from NASA’s Jet Propulsion Laboratory, were emailing me that this was likely for real. I started sending messages telling everyone to turn their telescopes to look at this object and started writing the paper to document what we know to date. We have data coming in from across the globe about this object.” The discovery Larry Denneau, a member of the ATLAS team reviewed and submitted the observations from the European Southern Observatory's Very Large Telescope in Chile shortly after it was observed on the night of July 1. Denneau said that he was cautiously excited. “We have had false alarms in the past about interesting objects, so we know not to get too excited on the first day. But the incoming observations were all consistent, and late that night it looked like we had the real thing. “It is especially gratifying that we found it in the Milky Way in the direction of the galactic center, which is a very challenging place to survey for asteroids because of all the stars in the background,” Denneau said. “Most other surveys don't look there.” John Tonry, another member of ATLAS and professor at the University of Hawaii, was instrumental in design and construction of ATLAS, the survey that discovered 3I. Tonry said, “It's really gratifying every time our hard work surveying the sky discovers something new, and this comet that has been traveling for millions of years from another star system is particularly interesting.” Once 3I/ATLAS was confirmed, Seligman and Karen Meech, faculty chair for the Institute for Astronomy at the University of Hawaii, both managed the communications flow and worked on getting the data pulled together for submitting the paper. “Once 3I/ATLAS was identified as likely interstellar, we mobilized rapidly,” Meech said. “We activated observing time on major facilities like the Southern Astrophysical Research Telescope and the Gemini Observatory to capture early, high-quality data and build a foundation for detailed follow-up studies.” After confirmation of the interstellar object, institutions from around the world began sharing information about 3I/ATLAS with Seligman. What scientists know about 3I/ATLAS so far Though data is pouring in about the discovery, it’s still so far away from Earth, which leaves many unanswered questions. Here’s what the scientific team knows at this point: It is only the third interstellar (meaning from outside our solar system) object to be detected passing through our solar system. It’s potentially giving off gas like other comets do, but that needs to be confirmed. It’s moving really fast at 60 kilometers per second, or 134,000 miles per hour, relative to the sun. It’s on an orbital path that is shaped like a boomerang or hyperbola. It’s very bright. It’s on a path that will leave our solar system and not return, but scientists will be able to study it for several months before it leaves. The James Webb Space Telescope and the Hubble Space Telescope are expected to reveal more information about its size, composition, spin and how it reacts to being heated over the next few months. “We have these images of 3I/ATLAS where it’s not entirely clear and it looks fuzzier than the other stars in the same image,” said James Wray, a professor at Georgia Tech. “But the object is pretty far away and, so, we just don’t know.” Seligman and his team are specifically interested in 3I/ATLAS’s brightness because it informs us about the evolution of the coma, a cloud of dust and gas. They’ve been tracking it to see if it has been changing over time as the object moves and turns in space. They also want to monitor for sudden outburst events in which the object gets much brighter. “3I/ATLAS likely contains ices, especially below the surface, and those ices may start to activate as it nears the sun,” Seligman said. “But until we detect specific gas emissions, like H₂O, CO or CO₂, we can’t say for sure what kinds of ice or how much are there.” The discovery of 3I/ATLAS is just the beginning. For Tessa Frincke, who came to MSU in late June to begin her career as a doctoral student with Seligman, having the opportunity to analyze data from 3I/ATLAS to predict its future path could lead to her publishing a scientific paper of her own. “I’ve had to learn a lot quickly, and I was shocked at how many people were involved,” said Frincke. “Discoveries like this have a domino effect that inspires novel engineering and mission planning.” For Atsuhiro Yaginuma, a fourth-year undergraduate student on Seligman’s team, this discovery has inspired him to apply his current research to see if it is possible to launch a spacecraft from Earth to get it within hundreds of miles or kilometers to 3I/ATLAS to capture some images and learn more about the object. “The closest approach to Earth will be in December,” said Yaginuma. “It would require a lot of fuel and a lot of rapid mobilization from people here on Earth. But getting close to an interstellar object could be a once-in-a-lifetime opportunity.” “We can’t continue to do this research and experiment with new ideas from Frincke and Yaginuma without federal funding,” said Seligman, who also is a postdoctoral fellow of the National Science Foundation. Seligman and Aster Taylor, who is a former student of Seligman’s and now a doctoral candidate in astronomy and astrophysics and a 2023 Fannie and John Hertz Foundation Fellow, wrote the following: “At a critical moment, given the current congressional discussions on science funding, 3I/ATLAS also reminds us of the broader impact of astronomical research. An example like 3I is particularly important to astronomy — as a science, we are supported almost entirely by government and philanthropic funding. The fact that this science is not funded by commercial enterprise indicates that our field does not provide a financial return on investment, but instead responds to the public’s curiosity about the deep questions of the universe: Where did we come from? Are we alone? What else is out there? The curiosity of the public, as expressed by the will of the U.S. Congress and made manifest in the federal budget, is the reason that astronomy exists.” In addition to MSU, contributors to this research and paper include European Space Agency Near-Earth Objects Coordination Centre (Italy), NASA Jet Propulsion Laboratory/Caltech (USA), University of Hawaii (USA), Auburn University (USA), Universidad de Alicante (Spain), Universitat de Barcelona (Spain), European Southern Observatory (Germany), Villanova University (USA), Lowell Observatory (USA), University of Maryland (USA), Las Cumbres Observatory (USA), University of Belgrade (Serbia), Politecnico di Milano (Italy), University of Michigan (USA), University of Western Ontario (Canada), Georgia Institute of Technology (USA), Universidad Diego Portales, Santiago (Chile) and Boston University (USA).

Georgia Southern biology professor named 2025-26 Fulbright U.S. Scholar to Vietnam

Stephen Greiman, Ph.D., associate professor of biology in Georgia Southern University’s College of Science and Mathematics, has been awarded a 2025-26 Fulbright U.S. Scholar award to Vietnam where he will lead a teaching and research project focused on parasite diversity in bats. “Dr. Greiman is further proof that Georgia Southern faculty are among the best in their fields,” said Avinandan (Avi) Mukherjee, Ph.D., provost and executive vice president for Academic Affairs. “We are incredibly proud of this achievement and all the hard work that goes into such a celebrated milestone paying off.” Greiman’s Fulbright work will build on more than a decade of collaboration with Vietnamese scientists. During graduate school, he began working with parasitologists in Vietnam and participated in field expeditions in 2013 and 2014. That early partnership has since blossomed into multiple co-authored publications and enduring collegial friendships. Vietnam, Greiman explained, is a natural fit for this project. “Its exceptional biodiversity and the significant burden of parasitic infections across humans, domestic animals and wildlife make it a particularly relevant and meaningful host country for my research,” he said. “Our shared goal is to advance awareness and understanding of parasite diversity among students and the public.” During his grant period, Greiman will teach a parasitology course at Hai Duong Medical Technical University. He will also conduct field and laboratory research in partnership with the Vietnam Academy of Science and Technology’s Institute of Ecology and Biological Resources and the Department of Parasitology. His research will involve sampling and analyzing the parasites and microbiomes of Vietnamese bats—a project designed to engage both undergraduate and graduate students in hands-on scientific inquiry. “International collaborations often yield more impactful research than national projects alone,” Greiman noted. “This award not only strengthens our scientific goals but offers my family a chance to immerse ourselves in a new culture. It’s an experience we’re incredibly grateful for.” Beyond fieldwork, Greiman hopes the Fulbright project will open doors for new exchange programs between Georgia Southern and Vietnamese institutions. He envisions Georgia Southern students spending semesters abroad and returning with global perspectives that enrich their academic and personal growth. “The data and experiences I bring back will directly inform my courses, including parasitology and biology of microorganisms,” Greiman said. “I’ll also use our findings to support undergraduate and graduate research projects, pursue new grant opportunities and publish in high-impact journals.” He credits the Fulbright program with not only enabling his research abroad but also cultivating cultural exchange, particularly by allowing families to travel with awardees. His wife, who has a background in the arts, is excited to explore Vietnam’s artistic traditions, while their two young children will experience a culture far different from their own. “Vietnam is rich in natural and cultural history,” he said. “We’re looking forward to embracing it fully, both in the field and in everyday life.” Greiman’s selection is both a professional milestone and a personal journey—one shaped by long-standing collaborations, a deep commitment to global science, and the mentorship of Georgia Southern Vice President for Research and Economic Development David Weindorf, Ph.D. “Although I was initially hesitant to apply due to the program’s competitiveness, I was inspired by Dr. Weindorf’s own transformative experiences as a Fulbright Scholar and Specialist,” Greiman said. “His guidance and support helped me see the incredible potential of this opportunity—not just for my research, but for my family and our students.” That encouragement reflects a strong professional relationship rooted in mutual respect and a shared commitment to international collaboration. “I am so proud of Dr. Greiman’s selection as a Fulbright Scholar,” said Weindorf. “The benefits of the exchange will truly be lifelong, with new friends, colleagues and connections formed and cultivated. We look forward to celebrating the lives Dr. Greiman touches, both through his teaching and research, as a meritorious ambassador of Georgia Southern University.” For Greiman, the Fulbright award marks just the beginning of a broader vision. “This experience will generate foundational data for future National Science Foundation and National Institutes of Health proposals and deepen our international partnerships,” he said. “Being selected as a Fulbright Scholar is an extraordinary honor and a chance to contribute meaningfully to a global legacy of scholarship, cultural exchange and scientific discovery.” He encourages fellow faculty members considering the program to apply. “Go for it,” he said. “Your chances are zero if you don’t try. The Fulbright is one of the few opportunities that blends extended research, cultural immersion and family inclusion. It’s life-changing—and absolutely worth it.” If you're interested in knowing more about Stephen Greiman's work or more about his Fullbright award - simply contact Georgia Southern's Director of Communications Jennifer Wise at jwise@georgiasouthern.edu to arrange an interview today.

Seniors Pay the Highest Price When Politicians Dismiss Healthcare Evidence

Disclaimer: This is an opinion piece. It reflects the author's perspective and should not be considered medical advice. Please consult with your physician or healthcare provider to discuss your individual health and vaccination needs. If you’re experiencing health issues, don’t rely on blogs (even snappy ones)—rely on a qualified medical professional. Fall is here. Kids are back in class, pumpkin spice is back in mugs, and—like clockwork—news headlines are back stirring fear and doubt. This season, RFK Jr. is making noise about vaccines, throwing science under the school bus, and leaving some older Canadians wondering: Who should I trust—politics or science? Spoiler: if you’re betting on politics to keep you healthy, you might as well ask your neighbour’s cat for medical advice. So, let’s get back to basics: what shots you really need, why the science is solid, why politics muddies the waters, and how you can be your own best health advocate. Oh, and because you know me—I’ll sprinkle in a few “if only” vaccines we all wish existed. Science vs. Politics: Who Wins? Science: Vaccines work. They reduce severe illness, save millions of lives, and prevent outbreaks of diseases we thought we’d left in history books. COVID-19 vaccines alone are credited with saving over 1.4 million lives in Europe since 2020. Vaccines aren’t some modern fad cooked up in a lab—they’ve been saving lives since 1796, when English doctor Edward Jenner made a discovery that led to the first smallpox vaccines, which at the time was one of the deadliest diseases on earth. Fast forward to today, and the results speak for themselves. Data from the CDC shows that vaccines have slashed major diseases in the U.S. and Canada to the point where polio and smallpox haven’t been seen in decades—down from tens of thousands of cases every year in the 20th century. Even measles, which has made a resurgence due to rising vaccine skepticism, is still nowhere near the half-million infections Americans used to see annually. Thanks to vaccines, measles, pertussis, mumps, and rubella are now more likely to show up in a history book—or on a pub trivia night—than in your family doctor’s office. Over a century of data shows that vaccines don’t just work—they’ve rewritten medical history. A landmark CDC study published in JAMA by researchers Sandra W. Roush (MT, MPH) and Trudy V. Murphy, MD, with Centers for Disease Control and Prevention, Atlanta, Georgia did a major study comparing disease rates before and after vaccines became widespread.  The results were jaw-dropping: Cases of diphtheria, mumps, pertussis, and tetanus dropped by more than 92%, and deaths by more than 99%. Endemic polio, measles, and rubella have been eliminated in the U.S and Canada. Smallpox is gone from the globe. Even newer vaccines introduced since 1980—like those for hepatitis A, hepatitis B, Hib, and chickenpox—cut cases and deaths by 80% or more. The evidence found by the CDC study was so overwhelming that the authors called vaccines “among the greatest achievements of biomedical science and public health” (Source: JAMA, 2007) The number of cases of most vaccine-preventable diseases is at an all-time low; hospitalizations and deaths have also shown striking decreases. Think about it. When was the last time someone at your dinner table worried about catching smallpox? Enter RFK Jr., stage left. He has wasted no time since his appointment as US Secretary of Health & Human Services to undermine confidence in the public health system.  His recent moves—firing the CDC director, cutting mRNA funding (even for cancer vaccines!), and gutting expert panels—are sowing doubt faster than a Toronto raccoon opening a green bin. Even Dr. Martin Makary, Commissioner of Food and Drugs for the U.S. Food and Drug Administration (FDA), recently chimed in with an opinion piece published last week in  The Wall Street Journal. His take? Vaccines should mostly be reserved for high-risk groups, healthy people don’t really need them, and maybe we should start running more placebo trials “just to be sure.” That sounds reasonable until you realize it’s the same playbook RFK Jr. uses: shrink access, shift the burden of proof endlessly, and treat vaccines like optional extras. When Politics Drowns Out Science, Seniors Pay the Highest Price When politics drowns out science, we pay the highest price. Because the truth is: our immune systems age just like our knees do—creaky and slower to respond. Vaccines aren’t optional; they’re essential. Demanding new placebo trials for vaccines we already know work is like asking a baker to prove yeast makes bread rise every single year. And framing vaccines as “only for the sick” ignores the basic truth: when coverage falls, outbreaks rise. Period. Vaccines for Canadian Adults & Seniors (Source: Health Canada) Vaccines aren’t just for kids—they’re part of healthy aging, too. Health Canada has issued clear guidelines on which shots adults and seniors should have on their radar, from flu and pneumonia to shingles and RSV. Think of it as a maintenance schedule for your immune system. That said, every person’s health history is unique, so always check with your doctor or healthcare provider before rolling up your sleeve. Flu shot (Seasonal Influenza Vaccine) – Protects against flu strains that mutate yearly (PHAC – Influenza Vaccine). Everyone should receive it annually; seniors may be eligible for a high-dose version. Pneumococcal (Pneu-C-20) – Shields you from pneumonia, bloodstream infections, and meningitis (PHAC – Pneumococcal Vaccine). One dose at 65+. Shingles (Recombinant Zoster Vaccine – RZV) – Stops the chickenpox virus (that never left your body) from staging a painful comeback tour (PHAC – Shingles Vaccine Guidance)—two doses, starting at age 50. Tdap (Tetanus, Diphtheria, Pertussis Vaccine) – Protects against lockjaw, a throat infection, and whooping cough (PHAC – Tdap Vaccine). One-time booster, then Tdap every 10 years. Polio (Inactivated Poliovirus Vaccine – IPV) – Keeps polio from making a comeback (PHAC – Polio Vaccine). Needed if you missed doses or travel to outbreak zones. RSV (Respiratory Syncytial Virus Vaccine) – Prevents serious lung infections in older adults (Health Canada – RSV Vaccine Information). Recommended for ages 75+ or in long-term care. MMR (Measles, Mumps, Rubella Vaccine) – Blocks childhood triple threats (PHAC – MMR Vaccine). One dose if born after 1970 and not immune. Varicella (Chickenpox Vaccine) – For those who have never had chickenpox (PHAC – Varicella Vaccine). Two doses under age 50; For those over 50, the shingles vaccine is recommended. The Vaccines We Wish Existed Because let’s face it: medicine has cured smallpox, but not small talk. RV – Rectitious Vision Correction: For correcting poor attitudes and selective hearing in spouses. FOMOVAX: Stops the green-eyed monster when your friends are on a Caribbean cruise and you’re at Costco. TechTonic: For when Zoom won’t unmute and your iPad keeps asking for your “Apple ID you made in 2009.” EarPeace: Selective hearing—blocks whining, amplifies compliments. WineNot: The Thanksgiving booster that helps you tolerate in-laws, politics talk, and Uncle Bob’s gravy complaints. MemoryMap: Protects against the “where did I put my glasses?” epidemic. Spoiler: they’re on your head. If only. Until then, we’ll have to stick with flu and shingles shots. Screening Schedule: The Other Half of the Health Checklist Keeping your health on track sometimes feels like managing a full-time maintenance schedule. After all, the human body has more moving parts than a Canadian Tire catalogue—so of course things need regular tune-ups. If vaccines are like scheduled oil changes for your immune system, screenings are more like the regular safety inspections—checking the brakes, the lights, and making sure nothing rattles when it shouldn’t. Our bodies have a knack for keeping secrets until it’s too late, which is why Health Canada and national guidelines recommend routine checks for cancer, heart health, bone strength, and more. Here’s the recommended Health Canada guidelines—your doctor may adjust based on your risk.: Cervical (Pap test): Every 3 years, ages 25–69 (CTFPHC – Cervical Cancer Guideline). Breast (Mammogram): Every 2–3 years, ages 50–74 (CTFPHC – Breast Cancer Screening). Colorectal (Colonoscopy or FIT test): Every 2 years (FIT) or 10 years (colonoscopy), ages 50–74 (CTFPHC – Colorectal Cancer Screening). Prostate (PSA test): Discuss with your doctor around age 50 (CTFPHC – Prostate Cancer Guideline). Lung Cancer Screening: For current/former heavy smokers, typically ages 55–74 (Canadian Partnership Against Cancer – Lung Cancer Screening). Bone Density (DXA scan): At 65+ or earlier if at risk (Osteoporosis Canada – BMD Testing). Blood Pressure & Cholesterol: Annual or as needed (Hypertension Canada Guidelines). Diabetes (A1C test): Every 3 years starting at 40 (Diabetes Canada – Clinical Guidelines). Your Fall Holistic Health Checklist Still with me?  Here's a checklist that I personally follow as a seasonal tune-up—part vaccines, part screenings, part lifestyle hacks. It’s not about chasing perfection; it’s about making sure you’ve got the energy to keep doing what you love (and maybe even outpace the grandkids). Whether you’re just easing into retirement, solidly in the groove, or rocking your seventies with style, these age-by-age tips will help you stay sharp, strong, and one step ahead of sneaky health surprises. Pre-Retirees (55–64) • Annual flu shot • Covid-19 shot • Start shingles series (50+) • Tdap booster if due • Immunization catch-up (MMR, polio, varicella) • Screenings: Pap, mammogram, colon, bloodwork • Exercise, hydrate, and learn to say no—yes, that’s preventive care too. Post-Retirees (65+) • Annual flu shot (high-dose if offered) • Covid-19 shot • Pneumococcal vaccine • RSV vaccine (75+ or communal living) • Shingles vaccine if not done • Screenings: colon, prostate, bone density, cholesterol, diabetes • Keep bones strong: vitamin D, weight training, and occasionally lifting grandkids count. Active Retirees (70+) • All of the above • Review meds and fall-prevention strategies • Stay social—book clubs, golf leagues, dance classes. Loneliness is a silent epidemic. • Advocate for friends, spouses, and grandkids—because being the family health quarterback matters. Your Best Shot: Be Your Own (and Your Community’s) Advocate Vaccines and screenings are only half the story—the other half is using your voice. Seniors have enormous influence, and when you speak up, policymakers listen. Here are a few ways to make sure your concerns don’t get lost in the shuffle: Start local. Write a short letter or email to your Member of Parliament, MPP, or Mayor. Personal stories are more powerful than statistics—tell them why vaccines, screenings, and health services matter to you and your community. Pick up the phone. Constituency offices actually log every call, so even a five-minute conversation with a staffer goes on record. Think of it as Yelp for public policy. Go public. A letter to the editor in your local paper or a well-placed comment at a town hall gets noticed by decision-makers. Be persistent (but polite). Politics moves slowly, but steady nudges add up. You don’t need to storm Parliament—just keep knocking on the door. You’ve spent a lifetime paying taxes, raising families, and building communities—you’ve earned the right to be heard. And let’s be real: nobody wants to mess with a senior who’s got a phone, an email list, and time to follow up. This fall, don’t let politics steal your peace of mind. Don’t let headlines plant seeds of doubt. Vaccines and screenings aren’t about fear—they’re about freedom: freedom to keep moving, keep laughing, keep living the “Hip, Fit & Financially Free” life you deserve. And until they invent the "WineNot" booster or the "MemoryMap" shot, your best defence is still the good old-fashioned flu, shingles, and pneumonia vaccines—plus the screening tests that catch sneaky stuff early. So roll up your sleeve. Book that screening. Be your own health advocate. And while you’re at it, sign your spouse up for the RV shot—because an attitude adjustment should absolutely be a household vaccine. Stay healthy. Don't Retire - Rewire! Sue Resources Want to dig deeper? Here are links to a few of my other health and wellness posts where I share practical tips, a little humour, and more ways to keep your retirement years strong, savvy, and stress-free. > The Retirement Games: From Sprint to Marathon, The New Retirement Reality > Life Hacks in Retirement: Strategies for Aging Well Also for each vaccine mentioned, here are some links to trusted sources of information.  Please consult with your physician or healthcare provider before commencing with any treatment. COVID-19 Public Health Agency of Canada (PHAC) - COVID-19: Spread, prevention and risks - https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks.html Flu Shot (Seasonal Influenza) Public Health Agency of Canada (PHAC) – Canadian Immunization Guide, Influenza Chapter: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-10-influenza-vaccine.html Pneumococcal (Pneu-C-20) PHAC – Canadian Immunization Guide, Pneumococcal Chapter: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-16-pneumococcal-vaccine.html Shingles (Recombinant Zoster Vaccine – RZV) PHAC – Shingles Vaccine Guidance: https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/shingles-vaccine.html Tdap (Tetanus, Diphtheria, Pertussis) PHAC – Tdap Vaccine - https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-21-tetanus-diphtheria-pertussis-vaccine.html Polio (IPV) PHAC – Polio Vaccine Guidance - https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/polio-vaccine.html RSV (Respiratory Syncytial Virus) - Health Canada – RSV Vaccine Information - https://www.canada.ca/en/health-canada/services/drugs-health-products/vaccines/respiratory-syncytial-virus.html MMR & Varicella - PHAC – Measles, Mumps, Rubella, Varicella Chapters: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines.html